| BUS | Bartholin, urethral, and Skene glands; busulfan |
|---|---|
| EGBUS | external genitalia, Bartholin, urethral, Skene glands |
| EUM | external urethral meatus |
| EUS | endoscopic ultrasound; external urethral sphincter |
| IUM | internal urethral meatus; intrauterine [fetus] malnourished; intrauterine membrane |
| urethral pressure profile | The continual recording of pressure through a hole in the side of a small catheter as it is pulled (at a constant rate while either water or a gas is infused through the hole) from a point within the bladder, through the vesical neck, and down the entire urethra; a form of resistance measurement which gives a tracing indicative of the functional length of the urethra and the points of maximal urethral resistance. (05 Mar 2000) |
|---|---|
| urethral stricture | <urology> A narrowing of the urethra that results from inflammation, injury or infection. (27 Sep 1997) |
| urethral surface of penis | The surface of the penis opposite to the dorsum penis. Synonym: facies urethralis penis. (05 Mar 2000) |
| urethral syndrome | <syndrome, urology> Symptoms of a urinary tract infection although the urine is sterile when analysed. This suggests the infection is localised to the urethra (urethritis). Treated with antibiotics. (27 Sep 1997) |
| urethral valves | Folds in the urethral mucous membrane. See: anterior urethral valve, posterior urethral valves. (05 Mar 2000) |
| bladder neoplasms | Cancers or tumours of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric. (12 Dec 1998) |
| bone marrow neoplasms | Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as myeloma. most bone marrow neoplasms are metastatic. (12 Dec 1998) |
| breast neoplasms, male | Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Two-thirds of patients present with intraductal carcinoma. The average age of onset is 60 years for men. Orchiectomy was the standard treatment but it has been replaced by tamoxifen as the initial therapy since oestrogen-receptor-positive tumours are predominant in males. Orchiectomy and mastectomy may be used if initial drug therapy is not successful. The prognosis is worse than that for females. (12 Dec 1998) |
| vascular neoplasms | <oncology> Neoplasms located in vascular tissue or specific veins. They are differentiated from neoplasms, vascular tissue which are neoplasms composed of vascular tissue, such as angiofibroma or haemangioma. (12 Dec 1998) |
| pancreatic cystic neoplasms | <radiology> Microcystic adenoma, glycogen, benign, mucinous cystic neoplasm, macrocystic adenoma, cystadenoma/cystadenocarcinoma, mucin, pre-malignant, Both occur more commonly in women, peak in middle age (12 Dec 1998) |
| pancreatic neoplasms | <radiology> Adenocarcinoma, most common, usually in pancreatic head, nasty (1-2% survival at 1 yr!), cystic neoplasms, slow-growing, more common in women, isleT-cell tumours, soft-tissue tumours (rare), metastases (breast, lung, melanoma, stomach, colon) (12 Dec 1998) |
| mammary neoplasms | Tumours of the mammary gland. Their occurrence is uncommon with the exception of the female dog, in which they account for 25% of all neoplasms. (12 Dec 1998) |
| paranasal sinus neoplasms | Neoplasms or tumours of the paranasal sinuses. Malignant neoplasms are rare, comprising 3% of all head and neck neoplasms. The majority arise in the maxillary sinus with malignancies of the ethmoid sinus constituting virtually all the remaining tumours. (12 Dec 1998) |
| genital neoplasms, male | Neoplasms of the male genitalia. (12 Dec 1998) |
| maxillary neoplasms | Cancer or tumours of the maxilla or upper jaw. (12 Dec 1998) |